Profluent releases the AI-designed OpenCRISPR-1 gene editor

Profluent released OpenCRISPR-1 molecular sequences and reported DNA editing in human cells using an AI-designed gene editor. The artifact was distinct from the company’s proprietary generative models, with use conditions including licensing for commercial therapeutic applications.